Catalyst Wire Dossier Catalyst Wire Dossier

Nirmatrelvir/Ritonavir (Paxlovid)

Nirmatrelvir/ritonavir · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nirmatrelvir/Ritonavir (Paxlovid), covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin [Phase 1]

See pricing